Study Warns of Diabetic Ketoacidosis With SGLT2 Inhibitors in T2D (CME/CE)

(MedPage Today) -- Doubled risk compared with DPP4 inhibitors
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news